Keyword: biologics

News

Catalent Starts Madison Expansion Project

28.10.2016 - Catalent Pharma Solutions has broken ground on a $34 million extension to its biologics manufacturing facility in Madison, Wisconsin, USA. When completed, the additional 22,000...

Markets & Companies

Bridging the Innovation Gap

02.09.2016 - During the last two decades the pharmaceutical industry was forced to undertake significant structural changes to address mounting challenges from strict regulatory policies, lower...

News

Drugmakers Find Canine Cancer Candidate

04.05.2016 - An R&D collaboration between Dublin, Ireland-based Nexvet Biopharma, a veterinary biologics developer, and Japanese animal health company Zenoaqa claims to have found fully...

News

Shire to Expand Biotech in Ireland

20.04.2016 - Ireland-based drugmaker Shire has announced an investment of $400 million to expand its global biotechnology manufacturing capacity in County Meath over the next four years. The...

Markets & Companies

After Pharma’s Patent Cliff

04.04.2016 - Analysts love looking into the future, particularly when it comes to big pharma’s prospect for growth and earnings. The industry experts of Morningstar see slowing patent losses...

Plant Construction & Process Technology

Innovative Medicine with Rising Productivity Targets

07.10.2015 - The need to get products quicker to market, to ensure greater regulatory compliance and to boost efficiencies while reducing operational cost is a challenging goal. Owing to the...

Plant Construction & Process Technology

Growth Amid Risk

07.10.2015 - Interest in the biopharma industry continues to grow, making the development and manufacturing services of the biologic entities for both drug substance and drug product a more...

Plant Construction & Process Technology

Chances and Hurdles for Biosimilars

07.10.2015 - With biosimilars the pharmaceutical industry and health-care business move into a relatively young discipline with high sales potential. The follow-up drugs of biopharmaceuticals...